Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials

Published:2022-01 Issue: Volume:175 Page:105902
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Thomopoulos Costas^ORCID,Ntalakouras John^ORCID,Polyzos Dimitris^ORCID,Konstantinidis Dimitris^ORCID,Palaiodimou Lina,Tsivgoulis Georgios,Tsioufis Costas

Publisher

Elsevier BV

Subject

Pharmacology

Reference57 articles.

1. ESC scientific document group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);Hindricks;Eur. Heart J.,2021

2. ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N. Engl. J. Med,2013

3. RE-LY steering committee and investigators. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med,2009

4. ARISTOTLE committees and investigators. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N. Engl. J. Med,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events;JAMA Neurology;2024-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP